Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)    
$53.75 0.02 (0.04%) as of 4:30 Fri 2/10


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 771,460,000 as of 12/25
Market Cap: 41.47(B)
Last Volume: 7,246,455 Avg Vol: 8,682,356
52 Week Range: $35.34 - $56.025
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Biotechnology

Member Indexes:
    S&P COMPOSITE 1500       NASDAQ BIOTECHNOLOGY  
    NASDAQ COMPOSITE       NASDAQ-100  
    S&P 500       NASDAQ NNM COMPOSITE  

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  410
Guru Rank Value     : 4
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics. Co. has operations in North America, Europe and Asia Pacific. Co.'s product portfolio includes: Atripla®, Truvada®, Viread® and Emtriva® for the treatment of human immunodeficiency virus infection; Hepsera® and Viread for the treatment of hepatitis B; AmBisome® for the treatment of severe fungal infections; Letairis® for the treatment of pulmonary arterial hypertension; Ranexa® for the treatment of chronic angina; Vistide® for the treatment of cytomegalovirus infection; and Cayston® as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa.
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 12,800
Total Buy Value $0 $0 $0 $494,039
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 395,770 606,410 1,468,470 2,137,476
Total Sell Value $20,056,014 $28,488,367 $63,884,296 $91,184,595
Total People Sold 6 6 6 7
Total Sell Transactions 10 16 35 61
End Date 2011-11-13 2011-08-12 2011-02-11 2010-02-11

   
Records found: 999
  Page 1 of 40  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Moore Nicholas G Director   –       •      –    2012-02-08 4 OE $19.44 $1,263,275 D/D 65,000 72,226     -
   Moore Nicholas G Director   –       •      –    2012-02-08 4 S $54.29 $3,528,766 D/D (65,000) 7,226 1%     
   Martin John C Chairman and CEO   •       •      –    2012-02-07 4 AS $54.92 $8,013,529 D/D (145,450) 1,949,215 -2%     
   Martin John C Chairman and CEO   •       •      –    2012-02-07 4 OE $8.94 $1,300,687 D/D 145,450 2,094,665     -
   Davignon Etienne Director   –       •      –    2012-02-07 4 S $55.26 $663,086 D/D (12,000) 600,391 2%     
   Anderson Kristen Metza SVP, Human Resources   •       –      –    2012-02-07 4 OE $34.69 $1,040,700 D/D 30,000 48,332     -
   Anderson Kristen Metza SVP, Human Resources   •       –      –    2012-02-07 4 S $55.04 $1,651,329 D/D (30,000) 18,332 2%     
   Washington Robin L SVP, CFO   •       –      –    2012-02-07 4 OE $38.17 $881,727 D/D 23,100 35,680     -
   Washington Robin L SVP, CFO   •       –      –    2012-02-07 4 S $54.92 $1,378,402 D/D (25,000) 10,680 2%     
   Washington Robin L SVP, CFO   •       –      –    2012-01-26 4 D $48.59 $66,617 D/D (1,371) 12,580     -
   Washington Robin L SVP, CFO   •       –      –    2012-01-26 4 A $0.00 $0 D/D 3,500 13,951     -
   Anderson Kristen Metza SVP, Human Resources   •       –      –    2012-01-10 4 OE $30.95 $578,228 D/D 18,000 24,832     -
   Anderson Kristen Metza SVP, Human Resources   •       –      –    2012-01-10 4 S $44.95 $809,100 D/D (18,000) 18,332 -21%     
   Milligan John F President and COO   •       –      –    2012-01-06 4 OE $8.22 $55,723 D/D 6,780 220,686     -
   Denny James M Director   –       •      –    2011-12-23 5 D $0.00 $0 D/D (30,000) 257,526     -
   Denny James M Director   –       •      –    2011-12-23 5 A $0.00 $0 I/I 30,000 30,000     -
   Milligan John F President and COO   •       –      –    2011-12-21 4 OE $8.22 $53,422 D/D 6,500 213,906     -
   Martin John C Chairman and CEO   •       •      –    2011-12-05 4 AS $40.00 $1,852,000 D/D (46,300) 1,949,215 34%     
   Martin John C Chairman and CEO   •       •      –    2011-12-05 4 OE $8.22 $380,530 D/D 46,300 1,995,515     -
   Martin John C Chairman and CEO   •       •      –    2011-12-02 4 AS $40.00 $52,000 D/D (1,300) 1,949,215 36%     
   Martin John C Chairman and CEO   •       •      –    2011-12-02 4 OE $8.22 $10,684 D/D 1,300 1,950,515     -
   Alton Gregg H EVP, Corp & Med Affairs   •       –      –    2011-12-01 4 OE $17.50 $122,482 D/D 7,000 45,790     -
   Alton Gregg H EVP, Corp & Med Affairs   •       –      –    2011-12-01 4 S $39.84 $318,734 D/D (8,000) 37,790 -35%     
   Martin John C Chairman and CEO   •       •      –    2011-12-01 4 OE $8.22 $367,545 D/D 44,720 1,993,935     -
   Martin John C Chairman and CEO   •       •      –    2011-12-01 4 AS $40.01 $1,789,068 D/D (44,720) 1,949,215 35%     
  999 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 40
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2010 J3SG.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us